Orchestrating Technology To The Patient℠: The MPB Lifecycle Strategy
February 3, 2026The Surgeon and the 510(k): Why Great Inventions Get Stuck
February 11, 2026
Medical Patents Broker Inc. By Kenneth Pearce, President
A common misconception in the medical device sector is that a Class I designation represents a "compliance-free" path to market. This is a dangerous fallacy.
While most Class I devices are exempt from Premarket Notification 510(k) requirements, patent owners frequently underestimate the rigorous infrastructure the FDA demands for a truly marketable asset. At Medical Patents Broker Inc. (MPB), we’ve observed that a patent’s value is dictated by more than just the invention—it is dictated by its regulatory readiness.
To avoid the hurdles of Class II or III, Class I devices must still adhere to "General Controls." When these aren't achieved to perfection, the FDA intervenes. Key pillars include:
- Establishment Registration & Device Listing: Active, accurate registration is a non-negotiable baseline.
- Quality Management System Regulation (QMSR): With the transition to the new QMSR standards earlier this month, 21 CFR 820 requires even more structured documentation. Records are the only proof of safety. Some records are far more expensive to reconstruct than they are to create correctly the first time.
- Labeling and Misbranding: The FDA maintains strict oversight on marketing. If your labeling hints at a use-case beyond Class I, you risk an upward "Class creep" that can devalue a patent’s sale price to a Class I manufacturer.
MPB’s Observation: For more than two and one-half millennia, Aesop’s Fable has instructed us that the Tortoise defeated the Hare. Slow, steady, meticulous and compliant wins the prize!
If you are a Seller/Licensor or a Buyer/Licensee, contact MPB via this website.
Medical Patents Broker Inc.
By Kenneth Pearce, President
